ZYGEL Trademark

Trademark Overview


On Monday, January 24, 2022, a trademark application was filed for ZYGEL with the United States Patent and Trademark Office. The USPTO has given the ZYGEL trademark a serial number of 97235095. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, June 27, 2024. This trademark is owned by Zynerba Pharmaceuticals, Inc.. The ZYGEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders...
zygel

General Information


Serial Number97235095
Word MarkZYGEL
Filing DateMonday, January 24, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZynerba Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDevon, PA 19333

Party NameZynerba Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDevon, PA 19333

Trademark Events


Event DateEvent Description
Thursday, January 27, 2022NEW APPLICATION ENTERED
Thursday, January 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 2, 2022ASSIGNED TO EXAMINER
Monday, November 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 6, 2023SOU EXTENSION 1 FILED
Thursday, July 6, 2023SOU EXTENSION 1 GRANTED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU EXTENSION 3 GRANTED
Thursday, June 27, 2024SOU EXTENSION 3 FILED
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 1, 2024SOU EXTENSION 2 FILED
Thursday, February 1, 2024SOU EXTENSION 2 GRANTED